| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
On November 17, 2025, Salarius Pharmaceuticals, Inc. (the "Company") became aware that certain financial market data pl...
Salarius Pharmaceuticals shares jumped 23.7% in after-hours trading Tuesday, closing at $1.21 following its public offering ann...